"<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<xml><records>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>1<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Samuele Cortese<\/author><author>Nicoletta Adamo<\/author><author>Cinzia Del Giovane et al.<\/author><\/authors><\/contributors><titles><title>Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis<\/title><secondary-title>The Lancet Psychiatry<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/s2215-0366(18)30269-4<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S2215036618302694\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Maura L. Gillison<\/author><author>Andy Trotti<\/author><author>Jonathan Harris et al.<\/author><\/authors><\/contributors><titles><title>Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(18)32779-x<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/6541928<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Hmwe Hmwe Kyu<\/author><author>Degu Abate<\/author><author>Kalkidan Hassen Abate et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(18)32335-3<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S0140673618323353\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Joshua A. Salomon<\/author><author>Juanita A. Haagsma<\/author><author>Adrian C. Davis et al.<\/author><\/authors><\/contributors><titles><title>Disability weights for the Global Burden of Disease 2013 study<\/title><secondary-title>The Lancet Global Health<\/secondary-title><\/titles><dates><year>2015<\/year><\/dates><electronic-resource-num>10.1016\/s2214-109x(15)00069-8<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S2214109X15000698\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Patrice Simon<\/author><author>Yury G. Gogotsi<\/author><\/authors><\/contributors><titles><title>Materials for electrochemical capacitors<\/title><secondary-title>Nature Materials<\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1038\/nmat2297<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/nmat2297.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>E. Ray Dorsey<\/author><author>Alexis Elbaz<\/author><author>Emma L. Nichols et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national burden of Parkinson&#039;s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016<\/title><secondary-title>The Lancet Neurology<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/s1474-4422(18)30295-3<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S1474442218302953\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Spencer Lewis James<\/author><author>Degu Abate<\/author><author>Kalkidan Hassen Abate et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017<\/title><secondary-title>The Lancet<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/s0140-6736(18)32279-7<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S0140673618322797\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Emma L. Nichols<\/author><author>Jaimie D Steinmetz<\/author><author>Stein Emil Vollset et al.<\/author><\/authors><\/contributors><titles><title>Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019<\/title><secondary-title>The Lancet Public Health<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1016\/s2468-2667(21)00249-8<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.thelancet.com\/pdfs\/journals\/lanpub\/PIIS2468-2667(21)00249-8.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Spencer Lewis James<\/author><author>Alice Theadom<\/author><author>Richard G. Ellenbogen et al.<\/author><\/authors><\/contributors><titles><title>Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016<\/title><secondary-title>The Lancet Neurology<\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.1016\/s1474-4422(18)30415-0<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S1474442218304150\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Richard J. Howarth<\/author><author>J.M. McArthur<\/author><\/authors><\/contributors><titles><title>Statistics For Strontium Isotope Stratigraphy: A Robust Lowess Fit to the Marine Sr\u2010Isotope Curve For 0 to 206 Ma, With Look\u2010Up Table For Derivation of Numeric Age<\/title><secondary-title>The Journal of Geology<\/secondary-title><\/titles><dates><year>1997<\/year><\/dates><electronic-resource-num>10.1086\/515938<\/electronic-resource-num><urls><related-urls><url>https:\/\/discovery.ucl.ac.uk\/10095892\/8\/Howarth_Statistics%20for%20strontium%20isotope%20stratigraphy-%20A%20robust%20LOWESS%20fit%20to%20the%20marine%20Sr-isotope%20curve%20for%200%20to%20206%20Ma%2C%20with%20look-up%20table%20for%20derivation%20of%20numeric%20age_VoR2.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>John P. Perdew<\/author><author>Alex Zunger<\/author><\/authors><\/contributors><titles><title>Self-interaction correction to density-functional approximations for many-electron systems<\/title><secondary-title>Physical review. B, Condensed matter<\/secondary-title><\/titles><dates><year>1981<\/year><\/dates><electronic-resource-num>10.1103\/physrevb.23.5048<\/electronic-resource-num><urls><related-urls><url>http:\/\/link.aps.org\/pdf\/10.1103\/PhysRevB.23.5048<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Laurent Excoffier<\/author><author>Peter E. Smouse<\/author><author>Joseph M. Quattro<\/author><\/authors><\/contributors><titles><title>Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data.<\/title><secondary-title>Genetics<\/secondary-title><\/titles><dates><year>1992<\/year><\/dates><electronic-resource-num>10.1093\/genetics\/131.2.479<\/electronic-resource-num><urls><related-urls><url>https:\/\/academic.oup.com\/genetics\/article-pdf\/131\/2\/479\/34572175\/genetics0479.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Cavalu S<\/author><author>Saber S<\/author><author>Ramadan A et al.<\/author><\/authors><\/contributors><titles><title>Unveiling citicoline&#039;s mechanisms and clinical relevance in the treatment of neuroinflammatory disorders.<\/title><secondary-title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1096\/fj.202400823R<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1096\/fj.202400823r<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Yoshikazu Okamoto<\/author><author>Pier-Luigi Di Patre<\/author><author>Christoph Burkhard et al.<\/author><\/authors><\/contributors><titles><title>Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas<\/title><secondary-title>Acta Neuropathologica<\/secondary-title><\/titles><dates><year>2004<\/year><\/dates><electronic-resource-num>10.1007\/s00401-004-0861-z<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Secades JJ<\/author><author>Gareri P<\/author><\/authors><\/contributors><titles><title>Citicoline: pharmacological and clinical review, 2022 update.<\/title><secondary-title>Revista de neurologia<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.33588\/rn.75s05.2022311<\/electronic-resource-num><urls><related-urls><url>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10548480\/pdf\/RN-75-S1.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kansakar U<\/author><author>Trimarco V<\/author><author>Mone P et al.<\/author><\/authors><\/contributors><titles><title>Choline supplements: An update.<\/title><secondary-title>Frontiers in endocrinology<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.3389\/fendo.2023.1148166<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1148166\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Jasielski P<\/author><author>Pi\u0119del F<\/author><author>Piwek M et al.<\/author><\/authors><\/contributors><titles><title>Application of Citicoline in Neurological Disorders: A Systematic Review.<\/title><secondary-title>Nutrients<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.3390\/nu12103113<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2072-6643\/12\/10\/3113\/pdf?version=1602752614<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bonvicini M<\/author><author>Travaglini S<\/author><author>Lelli D et al.<\/author><\/authors><\/contributors><titles><title>Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis.<\/title><secondary-title>Nutrients<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.3390\/nu15020386<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/2072-6643\/15\/2\/386\/pdf?version=1673510910<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Al-Kuraishy HM<\/author><author>Al-Buhadily AK<\/author><author>Al-Gareeb AI et al.<\/author><\/authors><\/contributors><titles><title>Citicoline and COVID-19: vis-\u00e0-vis conjectured.<\/title><secondary-title>Naunyn-Schmiedeberg&#039;s archives of pharmacology<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s00210-022-02284-6<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-022-02284-6.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fagone P<\/author><author>Jackowski S<\/author><\/authors><\/contributors><titles><title>Phosphatidylcholine and the CDP-choline cycle.<\/title><secondary-title>Biochimica et biophysica acta<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1016\/j.bbalip.2012.09.009<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/3562404<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"